Recombinant Human IL9 Protein，His

Interleukin 9 (IL-9) is a cytokine that plays a crucial role in the regulation of immune responses, particularly in the context of allergic diseases and asthma. It is primarily produced by a subset of CD4+ T helper cells, known as Th9 cells, and is involved in various physiological processes, such as the proliferation and activation of mast cells, the enhancement of IgE production by B cells, and the promotion of inflammation. Research into IL-9 and its recombinant protein has garnered significant attention due to its potential therapeutic applications. Elevated levels of IL-9 have been associated with allergic conditions, such as asthma, and its role in driving chronic inflammation makes it a key target for intervention. Recombinant IL-9 has been investigated for its effects on immune cell behavior and its influence on airway hypersensitivity. Furthermore, understanding the mechanisms of IL-9 signaling can lead to novel strategies for treating Th2-driven diseases. The exploration of IL-9’s function provides insights that may contribute to developing monoclonal antibodies or small-molecule inhibitors, aimed at modulating immune responses and offering new treatment options for patients suffering from allergic and autoimmune disorders. As such, the study of IL-9 as a recombinant protein not only enhances our understanding of immune regulation but also opens avenues for innovative therapeutic interventions.